Last reviewed · How we verify
NCT06189144
Testing an Intervention in Irritative Contact Dermatitis
NA trial testing Emollient cream treatment in Contact Dermatitis in 25 participants. Status unknown.
1 June 2024
Quick facts
| Lead sponsor | University of Split, School of Medicine |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 25 |
| Start date | 1 June 2023 |
| Primary completion | 1 June 2024 |
| Estimated completion | 1 June 2024 |
| Sites | 1 location across Croatia |
Drugs / interventions tested
- Emollient cream treatment
- no treatment — full drug profile →
Conditions studied
- Contact Dermatitis — all drugs for Contact Dermatitis →
- Contact Dermatitis Irritant — all drugs for Contact Dermatitis Irritant →
Sponsor
University of Split, School of Medicine
Who can join
Eligibility, any sex, with Contact Dermatitis or Contact Dermatitis Irritant. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
An eczematous reaction is an inflammatory intolerance response of the skin. In acute phase the reaction is characterized by erythema and blistering while in the chronic phase it presents as dryness, itchiness and lichenification. Irritative contact dermatitis describes these patterns of reaction in response to toxicity of chemicals on the skin cells, which trigger inflammation by activation of the innate immune system.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical Measurement of Transepidermal Water Loss.
Kundu D, Jayaraman A, Sen CK. · · 2026 · cited 4× · PMID 40476522 · DOI 10.1089/wound.2024.0148
Verify or expand the search:
- PubMed search for NCT06189144
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Split, School of Medicine trials
Trials by the same sponsor.
- NCT07286487 — Glycyrrhetinic Acid and Acute Irritant Dermatitis · NA · not yet recruiting
- NCT07314944 — Maternal Sleep and Lifestyle, Metabolic Health, and Perinatal Outcomes in Gestational Diabetes · recruiting
- NCT07140107 — Effectiveness of Original vs. AI-Generated Plain Language Summaries of Systematic Reviews · NA · enrolling by invitation
- NCT07078474 — Comparison of Skin Condition After Hyaluronic Acid Application on Dry vs. Moist Skin · NA · completed
- NCT07079371 — Micellar Water and the Skin Barrier: Comparing Rinsing vs. Non-Rinsing Application · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06189144 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Split, School of Medicine
- Last refreshed: 3 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06189144.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing